Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda 🌊, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth 🧠, renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care 💡; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology 🏥, academia 📚, and public health advocacy 🧬.

Profile

• Scopus

Education 🎓

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine 🎓; he earned a B.A. with High Honors in Music from Bowdoin College 🎵 (1977), pursued advanced coursework at MIT 🏛️, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole 🔬 — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation 📘.

Experience 👨‍🏫

With over three decades in clinical neurology 🧠, Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) 👨‍🏫; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 🏥, held multiple consultant roles across Vermont and New Hampshire 🗺️, and co-directs the Electromyography Lab ⚡, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments 🌟.

Awards & Recognitions 🏅

Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award 🏆 (2011); he is a Fellow of the American Academy of Neurology 🎖️ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology 🧠, complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education 📋💡.

Research Interests 🔬

Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS 🧬, exploring environmental toxins 🌿, nanotechnology 🧪, and biomarkers 🔍 to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology 🧠, he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues 🌍💡.